Results
1 -
8 of
8
(Click
here to explore results)
- Cholecystokinin-1 receptor antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents. E. Lattmann, S. T. Russell, C. H. Schwalbe, A. Shortt, P. N. Balaram, E. Theochari, M. Alharbi, R. Narayanan, P. Lattmann
, Med. Chem. Commun.
, 2016
, 7
, 1138
- Natural sweetener agave inhibits gastric emptying in rats by a cholecystokinin-2- and glucagon like peptide-1 receptor-dependent mechanism. E. Bihter Gürler, Dilek Özbeyli, Hülya Buzcu, Sezin Bayraktar, İrem Carus, Beyza Dağ, Yasemin Geriş, Seda Jeral, Berrak Ç. Yeğen
, Food Funct.
, 2017
, 8
, 741
- The chemistry and pharmacology of privileged pyrroloquinazolines. Bo Chao, Bingbing X. Li, Xiangshu Xiao
, Med. Chem. Commun.
, 2015
, 6
, 510
- Dynamic resolutions in asymmetric synthesis. S. Caddick, K. Jenkins
, Chem. Soc. Rev.
, 1996
, 25
, 447
- Natural products to drugs: natural product derived compounds in clinical trials. Mark S. Butler
, Nat. Prod. Rep.
, 2005
, 22
, 162
- Visible light-induced recyclable g-C3N4 catalyzed thiocyanation of C(sp2)–H bonds in sustainable solvents. Fan-Lin Zeng, Hu-Lin Zhu, Xiao-Lan Chen, Ling-Bo Qu, Bing Yu
, Green Chem.
, 2021
, 23
, 3677
- Multicomponent reactions as a potent tool for the synthesis of benzodiazepines. Hassan Farhid, Vida Khodkari, Mohammad Taghi Nazeri, Siamak Javanbakht, Ahmad Shaabani
, Org. Biomol. Chem.
, 2021
, 19
, 3318
- Natural products to drugs: natural product-derived compounds in clinical trials. Mark S. Butler
, Nat. Prod. Rep.
, 2008
, 25
, 475